Summit Securities Group’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.63K	Buy	+977	New	+$3.63K	﹤0.01%	871
2024 Q2	–	Sell	-142	Closed	-$5K	–	507
2024 Q1	$5K	Buy	+142	New	+$5K	﹤0.01%	245